INHIBITION OF PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) SIGNALLING LEADS TO RESISTANCE TO CHEMOTHERAPEUTIC AGENTS IN HUMAN CANCER CELLS
One of the major challenges associated with cancer therapy is the acquisition of chemoresistance by tumour cells. Many novel therapeutic approaches to overcome chemoresistance have involved targeting specific signalling pathways such as the phosphatidylinositol 3-kinase (PI3K) pathway, a stress res...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en en |
| Published: |
2008
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1974/1475 |